BridgeBio Oncology Therapeutics, Inc.
Nasdaq · CIK 0001869105 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-07-06 | 0001193125-26-296504 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-07-06 | 0001193125-26-296503 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-07-06 | 0001193125-26-296502 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-07-06 | 0001193125-26-296501 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-07-06 | 0001213900-26-075538 |
| 10-Q | BridgeBio Oncology Therapeutics, Inc. | 2026-05-12 | 0001193125-26-219829 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-05-05 | 0001193125-26-207041 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-05-05 | 0001193125-26-207035 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-05-05 | 0001193125-26-207031 |
| POS AM | BridgeBio Oncology Therapeutics, Inc. | 2026-04-30 | 0001193125-26-197901 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-03-12 | 0001193125-26-104384 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-03-12 | 0001193125-26-104379 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2026-03-12 | 0001193125-26-104369 |
| 10-K | BridgeBio Oncology Therapeutics, Inc. | 2026-03-05 | 0001193125-26-094112 |
| 8-K | BridgeBio Oncology Therapeutics, Inc. | 2026-03-05 | 0001193125-26-093997 |
| 10-Q | BridgeBio Oncology Therapeutics, Inc. | 2025-11-12 | 0001193125-25-277834 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2025-08-13 | 0001213900-25-075305 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2025-08-11 | 0001213900-25-074375 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2025-08-11 | 0001213900-25-074368 |
| 4 | BridgeBio Oncology Therapeutics, Inc. | 2025-08-11 | 0001213900-25-074364 |
| 10-Q | BridgeBio Oncology Therapeutics, Inc. | 2025-08-01 | 0001213900-25-070659 |